Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 5.31
(0.95%)
CNY 5.31
(0.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 343.25 Million CNY | 31.79% |
| 2022 | 208.98 Million CNY | 12.73% |
| 2021 | 185.38 Million CNY | 7.4% |
| 2020 | 172.61 Million CNY | -15.09% |
| 2019 | 203.29 Million CNY | -10.82% |
| 2018 | 227.96 Million CNY | 15.13% |
| 2017 | 198 Million CNY | 15.81% |
| 2016 | 170.97 Million CNY | 46.55% |
| 2015 | 116.66 Million CNY | -25.16% |
| 2014 | 155.88 Million CNY | 44.62% |
| 2013 | 107.79 Million CNY | 13.95% |
| 2012 | 94.59 Million CNY | 25.31% |
| 2011 | 75.48 Million CNY | -0.62% |
| 2010 | 75.95 Million CNY | 10.27% |
| 2009 | 68.88 Million CNY | -30.99% |
| 2008 | 99.81 Million CNY | -20.22% |
| 2007 | 125.11 Million CNY | 79.54% |
| 2006 | 69.68 Million CNY | 42.17% |
| 2005 | 49.01 Million CNY | 19.7% |
| 2004 | 40.94 Million CNY | -0.05% |
| 2003 | 40.97 Million CNY | 11.81% |
| 2002 | 36.64 Million CNY | 14.84% |
| 2001 | 31.9 Million CNY | 24.55% |
| 2000 | 25.61 Million CNY | -20.2% |
| 1999 | 32.1 Million CNY | 5.89% |
| 1998 | 30.31 Million CNY | 26.8% |
| 1997 | 23.9 Million CNY | 26.27% |
| 1996 | 18.93 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 73.84 Million CNY | 15.56% |
| 2024 Q1 | 74.6 Million CNY | -13.98% |
| 2024 Q2 | 74.77 Million CNY | 0.22% |
| 2023 Q3 | 73.05 Million CNY | 30.46% |
| 2023 Q4 | 86.73 Million CNY | 18.72% |
| 2023 Q1 | 59.63 Million CNY | 24.1% |
| 2023 FY | 275.41 Million CNY | 31.79% |
| 2023 Q2 | 55.99 Million CNY | -6.1% |
| 2022 FY | 208.98 Million CNY | 12.73% |
| 2022 Q4 | 48.05 Million CNY | -28.64% |
| 2022 Q1 | 33.05 Million CNY | -48.57% |
| 2022 Q2 | 60.53 Million CNY | 83.14% |
| 2022 Q3 | 67.33 Million CNY | 11.24% |
| 2021 FY | 185.38 Million CNY | 7.4% |
| 2021 Q1 | 35.32 Million CNY | -42.5% |
| 2021 Q2 | 35 Million CNY | -0.9% |
| 2021 Q3 | 50.77 Million CNY | 45.04% |
| 2021 Q4 | 64.27 Million CNY | 26.59% |
| 2020 FY | 172.61 Million CNY | -15.09% |
| 2020 Q4 | 61.43 Million CNY | 55.6% |
| 2020 Q2 | 34.14 Million CNY | -9.07% |
| 2020 Q3 | 39.48 Million CNY | 15.62% |
| 2020 Q1 | 37.55 Million CNY | -49.8% |
| 2019 Q1 | 41.15 Million CNY | -48.92% |
| 2019 Q3 | 35.02 Million CNY | -33.04% |
| 2019 Q4 | 74.8 Million CNY | 113.57% |
| 2019 FY | 203.29 Million CNY | -10.82% |
| 2019 Q2 | 52.3 Million CNY | 27.09% |
| 2018 Q1 | 37.33 Million CNY | -43.56% |
| 2018 FY | 227.96 Million CNY | 15.13% |
| 2018 Q4 | 80.57 Million CNY | 30.06% |
| 2018 Q3 | 61.95 Million CNY | 28.77% |
| 2018 Q2 | 48.1 Million CNY | 28.87% |
| 2017 Q4 | 66.14 Million CNY | 30.69% |
| 2017 FY | 198 Million CNY | 15.81% |
| 2017 Q1 | 40.34 Million CNY | -43.01% |
| 2017 Q2 | 40.9 Million CNY | 1.39% |
| 2017 Q3 | 50.61 Million CNY | 23.73% |
| 2016 Q1 | 34.39 Million CNY | 51.35% |
| 2016 Q2 | 34.21 Million CNY | -0.53% |
| 2016 Q4 | 70.78 Million CNY | 124.16% |
| 2016 FY | 170.97 Million CNY | 46.55% |
| 2016 Q3 | 31.57 Million CNY | -7.7% |
| 2015 Q4 | 22.72 Million CNY | -49.64% |
| 2015 FY | 116.66 Million CNY | -25.16% |
| 2015 Q3 | 45.13 Million CNY | 56.59% |
| 2015 Q2 | 28.82 Million CNY | 44.22% |
| 2015 Q1 | 19.98 Million CNY | -69.75% |
| 2014 FY | 155.88 Million CNY | 44.62% |
| 2014 Q4 | 66.05 Million CNY | 73.6% |
| 2014 Q3 | 38.05 Million CNY | 26.41% |
| 2014 Q2 | 30.1 Million CNY | 38.87% |
| 2014 Q1 | 21.67 Million CNY | -37.78% |
| 2013 FY | 107.79 Million CNY | 13.95% |
| 2013 Q4 | 34.83 Million CNY | 34.7% |
| 2013 Q3 | 25.86 Million CNY | -0.77% |
| 2013 Q2 | 26.06 Million CNY | 23.93% |
| 2013 Q1 | 21.03 Million CNY | -26.34% |
| 2012 FY | 94.59 Million CNY | 25.31% |
| 2012 Q1 | 16.38 Million CNY | -14.64% |
| 2012 Q3 | 22.98 Million CNY | -13.88% |
| 2012 Q2 | 26.68 Million CNY | 62.88% |
| 2012 Q4 | 28.55 Million CNY | 24.24% |
| 2011 Q2 | 21.43 Million CNY | 24.89% |
| 2011 Q1 | 17.15 Million CNY | -3.66% |
| 2011 FY | 75.48 Million CNY | -0.62% |
| 2011 Q4 | 19.19 Million CNY | 8.4% |
| 2011 Q3 | 17.7 Million CNY | -17.38% |
| 2010 Q3 | 13.41 Million CNY | -48.36% |
| 2010 Q4 | 17.81 Million CNY | 32.81% |
| 2010 FY | 75.95 Million CNY | 10.27% |
| 2010 Q1 | 18.76 Million CNY | -35.26% |
| 2010 Q2 | 25.97 Million CNY | 38.45% |
| 2009 Q2 | 13.78 Million CNY | 49.86% |
| 2009 Q4 | 28.98 Million CNY | 71.35% |
| 2009 FY | 68.88 Million CNY | -30.99% |
| 2009 Q3 | 16.91 Million CNY | 22.65% |
| 2009 Q1 | 9.2 Million CNY | -58.22% |
| 2008 FY | 99.81 Million CNY | -20.22% |
| 2008 Q4 | 22.02 Million CNY | -0.47% |
| 2008 Q3 | 22.12 Million CNY | -37.58% |
| 2008 Q2 | 35.45 Million CNY | 75.39% |
| 2008 Q1 | 20.21 Million CNY | -58.87% |
| 2007 Q3 | 37.45 Million CNY | 320.53% |
| 2007 Q4 | 49.14 Million CNY | 31.23% |
| 2007 Q2 | 8.9 Million CNY | -69.93% |
| 2007 Q1 | 29.61 Million CNY | 81.77% |
| 2007 FY | 125.11 Million CNY | 79.54% |
| 2006 Q1 | 15.39 Million CNY | -14.5% |
| 2006 Q2 | 20 Million CNY | 29.91% |
| 2006 Q3 | 17.99 Million CNY | -10.02% |
| 2006 Q4 | 16.29 Million CNY | -9.48% |
| 2006 FY | 69.68 Million CNY | 42.17% |
| 2005 FY | 49.01 Million CNY | 19.7% |
| 2005 Q2 | 10.05 Million CNY | 7.12% |
| 2005 Q4 | 18 Million CNY | 55.66% |
| 2005 Q1 | 9.38 Million CNY | -45.41% |
| 2005 Q3 | 11.56 Million CNY | 15.06% |
| 2004 FY | 40.94 Million CNY | -0.05% |
| 2004 Q4 | 17.19 Million CNY | 114.86% |
| 2004 Q3 | 8 Million CNY | 11.01% |
| 2004 Q1 | 8.54 Million CNY | -23.52% |
| 2004 Q2 | 7.2 Million CNY | -15.67% |
| 2003 Q4 | 11.17 Million CNY | 31.42% |
| 2003 Q2 | 8.8 Million CNY | -29.47% |
| 2003 FY | 40.97 Million CNY | 11.81% |
| 2003 Q1 | 12.48 Million CNY | -7.51% |
| 2003 Q3 | 8.5 Million CNY | -3.42% |
| 2002 Q1 | 8.25 Million CNY | 0.0% |
| 2002 Q4 | 13.49 Million CNY | 68.06% |
| 2002 Q3 | 8.03 Million CNY | 17.05% |
| 2002 Q2 | 6.86 Million CNY | -16.82% |
| 2002 FY | 36.64 Million CNY | 14.84% |
| 2001 FY | 31.9 Million CNY | 24.55% |
| 2000 FY | 25.61 Million CNY | -20.2% |
| 1999 FY | 32.1 Million CNY | 5.89% |
| 1998 FY | 30.31 Million CNY | 26.8% |
| 1997 FY | 23.9 Million CNY | 26.27% |
| 1996 FY | 18.93 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.36 Billion CNY | 74.834% |
| Zhejiang Zhenyuan Share Co., Ltd. | 654.18 Million CNY | 47.53% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 548.76 Million CNY | 37.45% |
| Yifan Pharmaceutical Co., Ltd. | 2.82 Billion CNY | 87.866% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 307.2 Million CNY | -11.734% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.5 Billion CNY | 95.429% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 564.68 Million CNY | 39.214% |
| Boai NKY Medical Holdings Ltd. | 309.15 Million CNY | -11.03% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 463.02 Million CNY | 25.868% |